A previous study reports that insulin crosses the blood–brain barrier and that peripheral insulin infusion in normal adult increases Aβ42 level in the cerebrospinal fluid, which makes it a surrogate marker of Aβ clearance and an indirect marker of brain and AD risk12. Here, INS is linked to Alzheimer disease.